Solana Company

Helius Medical Technologies (Nasdaq: HSDT) is a publicly traded firm that has recently changed its business model to include digital asset treasury management. Helius is now embracing the rapidly evolving world of digital assets as a key component of its business strategy. The company first gained recognition for its work on neurotechnology-based medical devices, which created innovative ways to treat neurological illnesses.

Helius is raising more than $100 million to establish a robust treasury focused on Solana, supporting this transition. The company's primary objective is to hold Solana's native token (SOL) as its primary reserve asset. This makes Helius one of the first U.S.-listed firms to base its balance sheet on a major layer-one blockchain token. Pantera Capital and Summer Capital, two well-known investors, are backing this move. Their engagement demonstrates that major institutions believe in the company's goals and the long-term future of the Solana ecosystem.

Helius will actively manage its treasury activities to make money and increase capital. Helius aims to receive staking rewards by participating in Solana's delegated staking mechanism. This will give them a consistent stream of income from their SOL holdings. The business also plans to explore various decentralized finance (DeFi) opportunities, including lending, providing liquidity, and other yield-generating protocols integrated into the Solana network. These actions are designed to maximize profits while adhering to stringent security and risk management criteria that are suitable for a publicly traded company.